About N.Cer

N.Cer develops AI-driven medical devices that employ machine learning algorithms to improve diagnostic accuracy and treatment effectiveness in healthcare. The technology provides precise, data-driven insights that enhance clinical decision-making, ultimately leading to better patient outcomes.

```xml <problem> Traditional methods for diagnosing cognitive impairment, such as Alzheimer's disease and dementia, often involve lengthy and complex procedures. This can lead to delays in diagnosis and treatment, increasing the burden on patients and their families. There is a need for faster, more accessible, and accurate diagnostic tools. </problem> <solution> N.Cer develops and provides AI-powered medical devices and solutions for the early detection and management of dementia. Their product line includes a rapid screening solution for mild cognitive impairment (MCI) using olfactory stimulation and a cerebral regional oximeter for real-time tissue oxygen saturation measurement. N.Cer leverages artificial intelligence and time-series data analysis to provide fast and accurate insights, enabling proactive intervention and comprehensive dementia care. Their solutions aim to reduce the suffering of families by facilitating quicker diagnoses and more effective management of cognitive decline. </solution> <features> - Alz Sniff: A screening program for rapid identification of patients with mild cognitive impairment using olfactory stimulation. - N1: A cerebral regional oximeter that measures real-time tissue oxygen saturation using near-infrared spectroscopy. - Brain Spa: A brain wellness device that uses light and sound stimulation to improve sleep quality and relieve stress. - AI-driven analysis for fast and accurate results. - Collaboration with top medical and research institutions. </features> <target_audience> N.Cer's primary customers are healthcare providers, including neurologists, geriatricians, and general practitioners, as well as hospitals and clinics specializing in dementia care and cognitive health. </target_audience> ```

What does N.Cer do?

Where is N.Cer located?

N.Cer is based in Gwangju, South Korea.

When was N.Cer founded?

N.Cer was founded in 2019.

Location

Gwangju, South Korea

Founded

2019

Find Investable Startups and Competitors

Search thousands of startups using natural language

AI voice (2021+)underground pipe robots energy flexibility software

Start Searching

N.Cer

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

ncerebro.com

Founded 2019 – Gwangju, South Korea

Funding

No funding information available.

Team

No team information available.

Company Description

Problem

Traditional methods for diagnosing cognitive impairment, such as Alzheimer's disease and dementia, often involve lengthy and complex procedures. This can lead to delays in diagnosis and treatment, increasing the burden on patients and their families. There is a need for faster, more accessible, and accurate diagnostic tools.

Solution

N.Cer develops and provides AI-powered medical devices and solutions for the early detection and management of dementia. Their product line includes a rapid screening solution for mild cognitive impairment (MCI) using olfactory stimulation and a cerebral regional oximeter for real-time tissue oxygen saturation measurement. N.Cer leverages artificial intelligence and time-series data analysis to provide fast and accurate insights, enabling proactive intervention and comprehensive dementia care. Their solutions aim to reduce the suffering of families by facilitating quicker diagnoses and more effective management of cognitive decline.

Features

Alz Sniff: A screening program for rapid identification of patients with mild cognitive impairment using olfactory stimulation.

N1: A cerebral regional oximeter that measures real-time tissue oxygen saturation using near-infrared spectroscopy.

Brain Spa: A brain wellness device that uses light and sound stimulation to improve sleep quality and relieve stress.

AI-driven analysis for fast and accurate results.

Collaboration with top medical and research institutions.

Target Audience

N.Cer's primary customers are healthcare providers, including neurologists, geriatricians, and general practitioners, as well as hospitals and clinics specializing in dementia care and cognitive health.